# Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes Mellitus

> **NCT00351000** · PHASE4 · COMPLETED · sponsor: **North Suffolk Mental Health Association** · enrollment: 24 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Ziprasidone

## Key facts

- **NCT ID:** NCT00351000
- **Lead sponsor:** North Suffolk Mental Health Association
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-01-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00351000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00351000, "Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes Mellitus". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00351000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*